Reports

Global Latex Particle for In-Vitro Diagnostics Competitive Landscape Professional Research Report 2025

Published:2025-05-10Pages:115Tables and Figures:130
Report ID:BJFL060402Report Format:Delivery:Within 72h

Full Report Selling Price
3500.00 USD
5250.00 USD
7000.00 USD
Buy NowContact Us
Competitor Data Selling Price
1000.00 USD
1500.00 USD
2000.00 USD
Buy NowContact Us
Important Clause:
Recently, our company has discovered that some websites have plagiarized, cited, and modified our original directories without authorization, seriously infringing on our company’s interests. In order to protect our intellectual property rights, we have decided not to publicly display specific enterprise lists, product segmentation types, and downstream applications. To view the complete content, please request a free sample.
*All report related content displayed on this website is original and our company has the sole copyright in DIReserch. Without prior permission from our company, it is not allowed to modify, reprint or cite in any way. Otherwise, our company reserves the right to pursue legal responsibility.
Research Scope
Table of Contents
Tables and Figures

Market Overview

According to DIResearch's in-depth investigation and research, the global Latex Particle for In-Vitro Diagnostics market size will reach 59.24 Million USD in 2025 and is projected to reach 88.96 Million USD by 2032, with a CAGR of 5.98% (2025-2032). Notably, the China Latex Particle for In-Vitro Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Latex particles for in-vitro diagnostics are specially engineered polymer microspheres used as reagents or carriers in medical testing systems to detect specific biomarkers, pathogens, or antibodies in blood, urine, or other biological samples. These particles are typically functionalized with reactive groups or coated with antibodies or antigens, enabling them to bind selectively to target molecules. Their uniform size and optical properties allow for precise and sensitive detection in assays such as latex agglutination tests, turbidimetric immunoassays, and lateral flow tests. By amplifying visible or measurable signals during biochemical reactions, they play a critical role in enhancing the speed, accuracy, and reliability of diagnostic results.

The major global  manufacturers of Latex Particle for In-Vitro Diagnostics include JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, VDO Biotech, Suzhou NanoMicro, Sunresin New Materials, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Latex Particle for In-Vitro Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Latex Particle for In-Vitro Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Latex Particle for In-Vitro Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Latex Particle for In-Vitro Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics Include:

JSR Life Sciences

Merck

Bangs Laboratories

Thermo Fisher

Agilent

IKERLAT Polymers

Fujikura Kasei

CD Bioparticles

VDO Biotech

Suzhou NanoMicro

Sunresin New Materials

Latex Particle for In-Vitro Diagnostics Product Segment Include:

Plain Latex Particles

Carboxy-Modified Latex Particles

Others

Latex Particle for In-Vitro Diagnostics Product Application Include:

Latex Immunoturbidimetry

Latex Agglutination Test

Immunochromatography

Others


Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Latex Particle for In-Vitro Diagnostics Industry PESTEL Analysis

Chapter 3: Global Latex Particle for In-Vitro Diagnostics Industry Porter’s Five Forces Analysis

Chapter 4: Global Latex Particle for In-Vitro Diagnostics Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Latex Particle for In-Vitro Diagnostics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Latex Particle for In-Vitro Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Latex Particle for In-Vitro Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Latex Particle for In-Vitro Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Latex Particle for In-Vitro Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Latex Particle for In-Vitro Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Latex Particle for In-Vitro Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Latex Particle for In-Vitro Diagnostics Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Competitor Data

Global Latex Particle for In-Vitro Diagnostics Revenue, Sales and Market Share by Player

Revenue (US$ Million)20202021202220232024
JSR Life SciencesXXXXXXXXXX
MerckXXXXXXXXXX
Bangs LaboratoriesXXXXXXXXXX
Thermo FisherXXXXXXXXXX
AgilentXXXXXXXXXX
IKERLAT PolymersXXXXXXXXXX
Fujikura KaseiXXXXXXXXXX
CD BioparticlesXXXXXXXXXX
VDO BiotechXXXXXXXXXX
Suzhou NanoMicroXXXXXXXXXX
Sunresin New MaterialsXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Sales (L)20202021202220232024
JSR Life SciencesXXXXXXXXXX
MerckXXXXXXXXXX
Bangs LaboratoriesXXXXXXXXXX
Thermo FisherXXXXXXXXXX
AgilentXXXXXXXXXX
IKERLAT PolymersXXXXXXXXXX
Fujikura KaseiXXXXXXXXXX
CD BioparticlesXXXXXXXXXX
VDO BiotechXXXXXXXXXX
Suzhou NanoMicroXXXXXXXXXX
Sunresin New MaterialsXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Order Process

Contact

1. Fill in your contact information, and the company will quickly match the specialist to get in touch with you

2. You can also directly call our customer service hotline or add customer service WeChat

Samples

1. One on one business specialist will send the complete version of the sample

2. If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples

Payment

1. Both parties sign a report purchase contract

2. Support Paypal, Visa, UnionPay and MasterCard Payment

Delivery

1. PDF report (sent online 2-3 working days after payment)

2. WORD version report (sent online 2-3 working days after payment)

3. Paper version report (sent via EMS or DHL within 3-5 working days after payment)

After-Sales

Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied

Didn't find the report you wanted? Please contact us!